Form 4: Gabelli Healthcare & WellnessRx Trust: Insider Buys Shares

Mario J. Gabelli, a director and control person of the adviser for Gabelli Healthcare & WellnessRx Trust, has acquired additional shares through various entities.

Summary

• Mario J. Gabelli, a director and control person of the adviser for Gabelli Healthcare & WellnessRx Trust, has reported purchasing shares of the company.
• On December 4, 2024, Mr. Gabelli acquired 137 shares at $10.50 each through Associated Capital Group, Inc.
• He also acquired 1,000 shares at $10.55 each directly and 2,000 shares at $10.50 each through a trust account.
• Mr. Gabelli indirectly owns a significant number of shares through Associated Capital Group, Inc. (8,000), a trust account (2,000), GGCP, Inc. (312,226), and GPJ Retirement Partners (6,380).
• Mr. Gabelli disclaims beneficial ownership of shares held by these entities in excess of his indirect pecuniary interest.

Sentiment

Score: 6

Explanation: The document indicates insider buying, which is generally a positive sign, but it's not a major event and doesn't provide a comprehensive view of the company's health.

Positives

• The insider purchase by a director and control person may signal confidence in the company's future prospects.
• The purchases were made at prices between $10.50 and $10.55, indicating a belief in the current valuation.

Risks

• The document does not provide any information about the company's overall financial health or future performance.
• The disclaimers of beneficial ownership by Mr. Gabelli for shares held by various entities could indicate a complex ownership structure.

Industry Context

Insider trading activity is closely monitored by investors as it can provide insights into management's view of the company's prospects. This filing indicates that a key insider is increasing their stake in the company.

Comparison to Industry Standards

• Insider trading activity is a common occurrence in publicly traded companies, and this filing is consistent with standard reporting requirements.
• The level of detail provided in the filing is typical for SEC Form 4 disclosures.

Stakeholder Impact

• The insider purchase may positively influence shareholder confidence.
• The transaction does not appear to have a direct impact on other stakeholders.

Key Dates

Keywords

insider trading, share purchase, beneficial ownership, Gabelli Healthcare & WellnessRx Trust, GRX, Mario J. Gabelli, director, control person